0001628280-19-015069.txt : 20191213 0001628280-19-015069.hdr.sgml : 20191213 20191213160629 ACCESSION NUMBER: 0001628280-19-015069 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191213 FILED AS OF DATE: 20191213 DATE AS OF CHANGE: 20191213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buckley Sean D. CENTRAL INDEX KEY: 0001744427 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31564 FILM NUMBER: 191284665 MAIL ADDRESS: STREET 1: C/O FIBROCELL SCIENCE, INC. STREET 2: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fibrocell Science, Inc. CENTRAL INDEX KEY: 0000357097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870458888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 484-713-6000 MAIL ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ISOLAGEN INC DATE OF NAME CHANGE: 20020320 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE DATE OF NAME CHANGE: 19960330 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO DATE OF NAME CHANGE: 19921008 4 1 wf-form4_157627117126415.xml FORM 4 X0306 4 2019-12-13 1 0000357097 Fibrocell Science, Inc. FCSC 0001744427 Buckley Sean D. FIBROCELL SCIENCE, INC. 405 EAGLEVIEW BLVD EXTON PA 19341 0 1 0 0 Chief Financial Officer Option to Purchase Common Stock 232.5 2019-12-13 4 D 0 200 D 2021-01-14 Common Stock 200.0 0 D Option to Purchase Common Stock 82.35 2019-12-13 4 D 0 334 D 2023-07-19 Common Stock 334.0 0 D Option to Purchase Common Stock 63.6 2019-12-13 4 D 0 1000 D 2025-04-01 Common Stock 1000.0 0 D Option to Purchase Common Stock 11.25 2019-12-13 4 D 0 2229 D 2026-09-27 Common Stock 2229.0 0 D Option to Purchase Common Stock 11.25 2019-12-13 4 D 0 4000 D 2027-03-16 Common Stock 4000.0 0 D Option to Purchase Common Stock 3.45 2019-12-13 4 D 0 5000 D 2028-01-25 Common Stock 5000.0 0 D Option to Purchase Common Stock 1.78 2019-12-13 4 D 0 30000 D 2029-04-12 Common Stock 30000.0 0 D Option to Purchase Common Stock 1.82 2019-12-13 4 D 0 15000 D 2029-08-18 Common Stock 15000.0 0 D Pursuant to the Merger Agreement, effective as of immediately prior to the effective time of the merger of the Company and Merger Sub, outstanding options, whether vested or not, became fully vested in accordance with the terms of the Merger Agreement and were canceled in exchange for a cash payment equal to the number of shares of Company common stock underlying the options multiplied by the excess of the per share merger consideration of $3.00 over the per share exercise price. /s/ Sean D. Buckley 2019-12-13